Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in North Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in North Carolina
| Provider | Medicare | Services |
|---|---|---|
| Laboratory Corporation Of America... | $17.69 | 8.5K |
| Quest Diagnostics Clinical... | $17.69 | 2.6K |
| Randolph, Teigha MD | $17.69 | 351 |
| Shahida, Shubi MD | $17.69 | 318 |
| Lane, Robert MD | $17.61 | 215 |
| Nelms, Wallace MD | $17.58 | 160 |
North Carolina Pricing in Context
In North Carolina, CPT code G0328 (Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous) carries an average Medicare payment of $17.65 — 0% above the national benchmark of $17.63. 582 providers across the state submitted claims for this procedure in 2023, performing 15.5K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in North Carolina is $86.31, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in North Carolina lands near $38.47, with self-pay cash prices typically around $36.97. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cost in North Carolina?
The average Medicare payment for Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in North Carolina is $17.65, which is 0% above the national average of $17.63. Providers in NC typically bill $86.31 for this procedure.
What does Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cost with insurance in North Carolina?
With commercial insurance in North Carolina, Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous costs an estimated $38.47. Without insurance, the estimated cash price is $36.97. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in North Carolina?
582 providers in North Carolina billed Medicare for Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in 2023, performing 15.5K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cheaper in North Carolina than the national average?
No — Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous costs 0% above the national average in North Carolina. The state average Medicare payment is $17.65 compared to $17.63 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.